Delayed Sleep Phase clinical trials at UCSF

2 research studies open to eligible people

Delayed Sleep Phase is when a person's sleep schedule is shifted later than normal. UCSF is looking for people to participate in clinical trials to test new treatments. One trial is testing a drug called Lemborexant to see if it's better than a placebo in helping people fall asleep faster. Another trial is testing a mobile health intervention to help improve sleep and mental health in teenagers.

Showing trials for

  • Lemborexant in Delayed Sleep Phase Syndrome

    open to eligible people ages 18 years and up

    The purpose of the study is to evaluate whether Lemborexant is more effective than placebo in shortening sleep onset latency in patients with delayed sleep phase syndrome (both type 1 and type 2). This will be tracked using sleep logs as well as actigraphy. In this 2-year study, we will examine if Lemborexant administered 5-10 mg nightly taken at desired bedtime (at least 2 hours prior to self-reported sleep onset habitual time) can improve the symptoms of Delayed Sleep Phase Syndrome.

    Redwood City, California

  • The Reducing Risk Study

    open to eligible people ages 12-18

    The present study will test an innovative mobile health adaptation of a behavioral intervention that improves sleep and mental health concerns among adolescents.

    San Francisco, California

Our lead scientists for Delayed Sleep Phase research studies include .

Last updated: